共 50 条
Hitting old targets better and identifying new targets
被引:10
作者:
Chen, Yu
[1
,2
]
Scher, Howard I.
[1
,2
]
机构:
[1] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA
关键词:
PROSTATE-CANCER;
MORTALITY;
D O I:
10.1038/nrclinonc.2011.213
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Options to treat late-stage castration-resistant prostate cancer continued to increase in 2011, as three agents with different mechanisms of action prolonged life and a fourth reduced the morbidity of skeletal metastases. These outcomes contrasted with the heightened controversy generated by the recommendation against PSA screening and other early detection strategies. Chen, Y. & Scher, H. I. Nat. Rev. Clin. Oncol. 9, 70-72 (2012); published online 10 January 2012; doi:10.1038/nrclinonc.2011.213
引用
收藏
页码:70 / 72
页数:3
相关论文
共 50 条